Hepatitis C: Risk factors and utility of screening tests;Hepatite C: Facteurs de risque et interet du depistage

Gastroenterologie Clinique et Biologique

Volumn 21, Issue 1 BIS, 1997, Pages

  Musset, Lucile ^a   Pham, Bach Nga ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b BEAUJON HOSPITAL   (France)

Author keywords

epidemiology; hepatitis C virus; risk factors; screening

Indexed keywords

BLOOD TRANSFUSION; CONFERENCE PAPER; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL INFECTION; INTRAVENOUS DRUG ABUSE; ORGAN TRANSPLANTATION; RISK FACTOR; SCREENING; SEXUAL TRANSMISSION; VERTICAL TRANSMISSION; VIRUS TRANSMISSION; DISEASE TRANSMISSION; HUMAN; INSTRUMENTATION; MASS SCREENING; METHODOLOGY; REVIEW;

HEPATITIS C; HUMANS; MASS SCREENING; RISK FACTORS;

EID: 0030934679     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (102)

1. Lucidarme D, Foutrein P, Creusy C, Forzy G, Foutrein-Comes MC, Muyssen A, et al. Prévalence des marqueurs des hépatites C, B et D et aspects histopathologiques dans un groupe de toxicomanes intraveineux. Gastroenterol Clin Biol 1994;18:964-8.
2. Crofts N, Hopper JL, Bowden DS, Breschkin AM, Milner R, Locamini SA. Hepatitis C infection among a cohort of Victorian injecting drug users. Med J Aust 1993;159:237-41.
3. Stark K, Schreier E, Müller R, Wirth D, Driesel G, Bienzle U. Prevalence and determinants of anti-HCV seropositivity and of HCV genotype among intravenous drug users in Berlin. Scand J Infect Dis 1995;27:331-7.
4. DuRant HD, Rickert VI, Ashworth CS, Newman C, Slavens G. Use of multiple drugs among adolescents who use anabolic steroids. N Engl J Med 1993;328:922-6.
5. Simmonds P, Rose KA, Graham S, Chan SW, McOmish F, Dow BC, et al. Mapping of serotype-specific, immunodominant epitopes in the NS4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2 and 3. J Clin Microbiol 1993;31:1493-503.
6. Pawlotsky JM, Tsakiris L, Roudot-Thoraval F, Pellet C, Stuyver L, Duval J et al. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis 1995;171:1607-10.
7. Silini E, Bono F, Cividini A, Cerino A, Maccabruni A, Tinelli C, et al. Molecular epidemiology of hepatitis C virus infection among intravenous drug users. J Hepatol 1995;22:691-5.
8. Conry-Cantilena C, VanRaden M, Gibble J, Melpolder J, Shakil O, Viladomiu L, et al. Route of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996;26:1691-6.
9. Donahue JG, Munoz A, Ness PM, Brown DE, Yawn DH, McAllister HA, et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992;327:369-73.
10. Riggert J, Schwartz DWM, Uy A, Simson G, Jelinek F, Fabritz H, et al. Risk of hepatitis C virus (HCV) transmission by anti-HCV-negative blood components in Austria and Germany. Ann Hematol 1996;72:35-9.
11. Pawlolsky JM, Bouvier M, Deforges L, Duval J, Bierling P, Dhumeaux D. Chronic hepatitis C after high-dose intravenous immunoglobulins. Transfusion 1994;34:86-7
12. Bjoro K, Froland SS, Yun Z, Samdal HH, Haaland T. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. N Engl J Med 1994;331:1607-11.
13. Yap PL, McOmish F, Webster ADB, Hammarstrom L, Smith CIE, Bjorkander J, et al. Hepatitis C virus transmission by intravenous immunoglobulin. J Hepatol 1994;21:455-60.
14. Healey CJ, Sabharwal NK, Daub J, Davidson F, Yap PL, Fleming KA, et al. Outbreak of acute hepatitis C following the use of anti-hepatitis C virus - screened intravenous immunoglobulin therapy. Gastroenterology 1996;110:1120-6.
15. Power JP, Lawlor E, Davidson F, Holmes EC, Yap PL, Simmonds P. Hepatitis C viremia in recipients of Irish intravenous anti-D immunoglobulin. Lancet 1994;344:1166-7.
16. Hou CH, Chen WY, Kao JH, Chen DS, Yang Y, Chen JJ, et al. Intrafamilial transmission of hepatitis C virus in hemodialysis patients. J Med Virol 1995;45:381-5.
17. Nakayama E, Liu JH, Akiba T, Marumo F, Sato C. Low prevalence of anti-hepatitis C virus antibodies in female hemodialysis patients without blood transfusion: a multicenter analysis. J Med Virol 1996;48:284-8.
18. Jadoul M, Cornu C, Van Ypersele de Strihou C and the UCL Collaborative Group. Incidence and risk factors for hepatitis C seroconversion in hemodialysis: a prospective study. Kidney Int 1993;44:1322-6.
19. Conway M, Catterall AP, Brown EA, Tibbs C, Gower PE, Curtis JR, et al. Prevalence of antibodies to hepatitis C in dialysis patients and transplant recipients with possible routes of transmission. Nephrol Dial Transplant 1992;7:1226-9.
20. Sakamoto N, Enomoto N, Marumo F, Sato C. Prevalence of hepatitis C virus infection among long-term hemodialysis patients: detection of hepatitis C virus RNA in plasma. J Med Virol 1993;39:11-5.
21. Jonas MM, Zilleruelo GE, LaRue SI, Abitbol C, Strauss J, Lu Y. Hepatitis C infection in a pediatric dialysis population. Pediatrics 1992;89:707-9.
22. Okuda K, Hayashi H, Kobayashi S, Irie Y. Mode of hepatitis C infection not associated with blood transfusion among chronic hemodialysis patients. J Hepatol 1995;23:28-31.
23. Neto MC, Draibe SA, Suva AEB, Ferraz ML, Granato C, Pereira CAP. Incidence of and risk factors for hepatitis B virus and hepatitis C virus infection among haemodialysis and CAPD patients: evidence for environmental transmission. Nephrol Dial Transplant 1995;10:240-6.
24. Allander T, Medin C, Jacobson SH, Grillner L, Persson MAA. Hepatitis C transmission in a hemodialysis unit: molecular evidence for spread of virus among patients not sharing equipment. J Med Virol 1994;43:415-9.
25. Favero MS. Recommended precautions for patients undergoing hemodialysis who have AIDS or non-A, non-B hepatitis. Infect Control 1985;6:301-5.
26. Hubmann R, Zazgornik J, Gabriel C, Garbeis B, Blauhut B. Hepatitis C virus - does it penetrate the haemodialysis membrane ? Nephrol Dial Transplant 1995;10:541-2
27. Sampietro M, Graziani G, Badalamenti S, Salvadori S, Caldarelli P, Como G, et al. Detection of hepatitis C virus in dialysate and in blood ultrafiltrate of HCV-positive patients. Nephron 1994;68:140.
28. Pol S, Legendre C. Les hépatites virales chez les patients hémodialysés et transplantés rénaux. Néphrologie 1994;15:191-5.
29. Pereira BJG, Wright TL, Schmid CH, Levey AS. A controlled study of hepatitis C transmission by organ transplantation. Lancet 1995;345:484-7.
30. Tesi RJ, Waller K, Morgan CJ, Delaney S, Elkhammas EA, Henry ML, et al. Transmission of hepatitis C by kidney transplantation. The risks. Transplantation 1994;57:826-31.
31. Esteban JI, Gomez J, Martell M, Cabot B, Quer J, Camps J, et al. Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med 1996;334:555-60.
32. Tennenbaum R, Colardelle P, Chochon M, Maisonneuve P, Jean F, Andrieu J. Hépatite C après cholangiographie rétrograde. Gastroenterol Clin Biol 1993;17:763-75
33. Rey JF, Halfon P, Feryn JM, Khiri H, Masseyeff MF, Ouzan D. Risque de transmission du virus de l'hépatite C par l'endoscopie digestive. Gastroenterol Clin Biol 1995;19:346-9.
34. Andrieu J, Bamy S, Colardelle P, Maisonneuve P, Giraud V, Robin E, et al. Prévalence et facteurs de risque de l'infection par le virus de l'hépatite C dans une population hospitalisée en Gastroentérologie. Rôle des biopsies per-endoscopiques, Gastroenterol Clin Biol 1995;4:340-5.
35. British Society of Gastroenterology. Cleaning and disinfection of equipement for gastrointestinal flexible endoscopy: interim recommandations of a working party. Gut 1988;29:1134-51.
36. Hayashi J, Kishihara Y, Yamaji K, Yoshimura E, Kawakami Y, Akazawa K, et al. Transmission of hepatitis C virus by health care workers in a rural area of Japan. Am J Gastroenterol 1995;90:794-9.
37. Allander T, Gruber A, Naghavi M, Beyene A, Söderström T, Björkholm M, et al. Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward. Lancet 1995;345:603-7.
38. Petrosillo N, Puro V, Ippolito G, Di Nardo V, Albertoni F, Chiaretti B, et al. Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in health care workers: a multiple regression analysis of risk factors. J Hosp Infect 1995;30:273-81.
39. Klein RS, Freeman K, Taylor PE, Stevens CE. Occupation risk for hepatitis C virus infection among New York City dentists. Lancet 1991;338:1539-42.
40. Germanaud J, Barthez JP, Causse X. The occupational risk of hepatitis C infection among hospital employees. Am J Public Health 1994;84:122.
41. Herbert AM, Walker DM, Davis KJ, Bagg J. Occupationally acquired hepatitis C virus infection. Lancet 1992;339:305.
42. Norrgren H, Flodman-Norrlund I, Lindholm T, Hansson BG, Nordenfelt E. Prevalence of antibodies against hepatitis B and C viruses among different groups of medical staff. Scand J Infect Dis 1992;24:553-4.
43. Thomas DL, Factor SH, Kelen GD, Washinton AS, Taylor E, Quinn TC. Viral hepatitis in health care personnel at The Johns Hopkins Hospital. Arch Intern Med 1993;153:1705-12.
44. Thomas DL, Gruninger SE, Siew C, Joy ED, Quinn TC. Occupational risk of hepatitis C infections among general dentists and oral surgeons in North America. Am J Med 1996;100:41-5.
45. Hoffmann H, Kunz C. Low risk of health care workers for infection with hepatitis C virus. Infection 1990;18:286-8.
46. Goetz AM, Ndimbie OK, Wagener MM, Muder RR. Prevalence of hepatitis C infection in health care workers affiliated with a liver transplant center. Transplantation 1995;59:990-4.
47. Abb J. Ocupationally acquired hepatitis C virus infection. Lancet 1992;339:304.
48. Carpentier E, Cottin J, Kouyoumdjian S, Bidet ML, Carbonnelle B. Prévalence des anticorps anti-virus de l'hépatite C dans une population hospitalière. Gastroenterol Clin Biol 1993;17:143-4.
49. Germanaud J, Barthez JP, Causse X. Prévalence des anticorps anti-virus de l'hépatite C chez le personnel d'un centre hospitalier français. Gastroenterol Clin Biol 1993;17:302-3.
50. Cooper BW, Krusell A, Tilton RC, Goodwin R, Lewitz RE. Seroprevalence of antibodies to hepatitis C virus in high-risk hospital personnel. Infect Control Hosp Epidemiol 1992;13:82-5.
51. Niu MT, Alter MJ, Kristensen C, Margolis HS. Outbreak of hemodialysis-associated non-A, non-B hepatitis and correlation with antibody to hepatitis C virus. Am J Kidney Dis 1992;19:345-52.
52. Kiyosawa E, Sodeyama T, Tanaka E, Nakano Y, Furuta S, Nishioka K, et al. Hepatitis C in hospital employees with needlestick injuries. Ann Intern Med 1991;115:367-9.
53. Mitsui T, Iwano K, Masuko K, Chikao Y, Hiroaki O, Fumio T, et al. Hepatitis C virus infection in medical personnel after needlestick accident. Hepatology 1992;16:1109-14.
54. Moore SB, Kruger JR, Rakela J, Vamvakas EC, Schimek C, Germer JJ, et al. Blood donors who are repeatedly reactive for hepatitis C virus on enzyme immunoassay and positive on recombinant immunoblot assay: evidence of failure to identify some risk factors. Transfusion 1995;35:308-12.
55. Sartori M, La Terra G, Aglietta M, Manzin A, Navino C, Verzetti G. Transmission of hepatitis C via blood splash into conjunctiva. Scand J Infect Dis 1993;25:270-1.
56. Suzuki K, Mizokami M, Lau JYN, Mizoguchi N, Kato K, Mizuno Y, et al. Confirmation of hepatitis C virus transmission through needlestick accidents by molecular evolutionary analysis. J Infect Dis 1994;170:1575-8.
57. Lissen E, Alter HJ, Abad MA, Torres Y, Pérez-Romero M, Leal M, et al. Hepatitis C virus infection among sexually promiscuous groups and the heterosexual partners of hepatitis C virus infected index cases. Eur J Clin Microbiol Infect Dis 1993;12:827-31.
58. Buchbinder SP, Katz MH, Hessol NA, Liu J, O'Malley PM, Alter MJ. Hepatitis C virus infection in sexually active homosexual men. J Infect 1994;29:263-9.
59. Nakashima K, Kashiwagi S, Hayashi J, Noguchi A, Hirata M, Kajiyma W, et al. Sexual transmission of hepatitis C virus among female prostitutes and patients with sexually transmitted diseases in Fukuoka, Kyushu, Japan. Am J Epidemiol 1992;136:1132-7.
60. Stary A, Kopp W, Hofmann H, Heller-Vitouch C, Kunz C. Seroepidemiologic study of hepatitis C virus in sexually transmitted disease risk groups. Sex Transm Dis 1992;19:252-8.
61. Osmond DH, Charlebois E, Sheppard HW, Page K, Winkelstein W, Moss AR, et al. Comparison of risk factors for hepatitis C and hepatitis B virus infection in homosexual men. J Infect Dis 1993;167:66-71.
62. Thomas DL, Zenilman JM, Alter HJ, Shin JW, Galai N, Carrela AV, et al. Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore. An analysis of 309 sex partnerships. J Infect Dis 1995;171:768-75.
63. Brakmann SA, Gerritzen A, Oldenburg J, Brackmann HH, Schneweis KE. Search for intrafamilial transmission of hepatitis C virus in hemophilia patients. Blood 1993;4:1077-82.
64. Osmond DH, Padian NS, Sheppard W, Glass S, Shiboski SC, Reingold A. Risk factors for hepatitis C virus seropositivity in heterosexual couples. JAMA 1993;269:361-5.
65. Shev S, Hermodsson S, Lindholm A, Malm E, Widell A, Norkrans G. Risk factor exposure among hepatitis C virus RNA positive Swedish blood donors. The role of parenteral and sexual transmission. Scand J Infect Dis 1995;27:99-104.
66. Solo B, Rodrigo L, Garcia-Bengoechea M, Sanchez-Quijano A, Riestra S, Arenas JI, et al. Heterosexual transmission of hepatitis C virus and the possible role of coexistent human immunodeficiency virus infection in the index case. A multicentre study of 423 pairings. J Intern Med 1994;236:515-9.
67. Chayama K, Kobayashi M, Tsubota A, Koida I, Arase Y, Saitoh S, et al. Molecular analysis of intraspousal transmission of hepatitis C virus. J Hepatol 1995;22:431-9.
68. Diago M, Zapater R, Tuset C, Carbonell P, Gonzalez C, Cors R, et al. Intrafamily transmission of hepatitis C virus: sexual and non-sexual contacts. J Hepatol 1996;25:125-8.
69. Utsumi T, Hashimoto E, Okumura Y, Takayanagi M, Nishikawa H, Kigawa M, et al. Heterosexual activity as a risk factor for the transmission of hepatitis C virus. J Med Virol 1995;46:122-5.
70. David XR, Blanc P, Pageaux GP, Desprez D, Diaz D, Lemaire JM, et al. Transmission familiale du virus de l'hépatite C. Gastroenterol Clin Biol 1995;19:150-5.
71. Deny P, Roulot D, Asselot C, Rauzy M, Rautureau J, Coste T. Low rate of hepatitis C virus (HCV) transmission within the family. J Hepatol 1992;14:409-10.
72. Scaraggi FA, Lomuscio S, Perricci A, De Mitrio V, Napoli N, Schiraldi O. Intrafamilial and sexual transmission of hepatitis C virus. Lancet 1993;342:1300-1.
73. Camarero C, Martos I, Delgado R, Suarez L, Escobar H, Mateos M. Horizontal transmission of hepatitis C virus in households of infected children. J Pediatr 1993;123:98-9.
74. Kiyosawa K, Tanaka E, Sodeyama T, Yoshizawa K, Yabu K, Furuta K et al, Liver, pancreas and biliary tract. Transmission of hepatitis C in an isolated area in Japan: community-acquired infection. Gastroenterology 1994;106:1596-602.
75. Oshita M, Hayashi N, Kasahara A, Yuki N, Takehara T, Hagiwara H, et al. Prevalence of hepatitis C virus in family members of patients. J Med Virol 1993;41:251-5.
76. Chang TT, Liou TC, Young KC, Lin XZ, Lin CY, Shin JS. Intrafamilial transmission of hepatitis C virus: the important role of inapparent transmission. J Med Virol 1994;42:91-6.
77. Ogasawara S, Kage M, Kosai K, Shimamatsu K, Kojiro M. Hepatitis C virus RNA in saliva and breastmilk of hepatitis C carrier mothers. Lancet 1993;341:561.
78. Couzigou P, Richard L, Dumas F, Schouler F, Fleury H. Detection of HCV-RNA in saliva of patients with chronic hepatitis C. Gut 1993;34:S59-60.
79. Liou TC, Chang TT, Young KC, Lin XZ, Lin CY, Wu HL. Detection of HCV RNA in saliva, urine, seminal fluid and ascites. J Med Virol 1992;37:197-202.
80. Giacchino R, Picciotto A, Tasso L, Timitilli A, Sinelli N. Vertical transmission of hepatitis C. Lancet 1995;345.1123.
81. Novati R, Thiers V, D'Arminio Monforte A, Maisonneuve P, Principi N, Conti M, et al. Mother-to-child transmission of hepatitis C virus detected by nested polymerase chain reaction. J Infect Dis 1992;165:720-3.
82. Lin HH, Kao JH, Hsu HY, Ni YH, Yen SH, Hwang LH, et al. Possible role of high-titer maternal viremia in perinatal transmission of hepatitis C virus. J Infect Dis 1994;169:638-41.
83. Manzini P, Saracco G, Cerchier A, Riva C, Musso A, Ricotti E, et al. Human immunodeficiency virus infection as risk factor for mother-to-child hepatitis C virus transmission; persistence of anti-hepatitis C virus in children is associated with the mother's anti-hepatitis C virus immunobloting pattern. Hepatology 1995;21:328-32.
84. Reinus JF, Leikin EL, Alter HJ, Cheung L, Shindo M, Jett B, et al. Failure to detect vertical transmission of hepatitis C virus. Ann Intern Med 1992;117:881-6.
85. Wejstal R, Widell A, Mansson AS, Hermodsson S, Gunnar N. Mother-to-infant transmission of hepatitis C virus. Ann Intern Med 1992;117:887-90.
86. Roudot Thoraval F, Pawlotsky JM, Thiers V, Deforges L, Girollet PP, Guillot F, et al. Lack of mother-to-infant transmission of hepatitis C virus in human immunodeficiency virus-seronegative women: a prospective study with hepatitis C virus RNA testing. Hepatology 1993;17:772-7.
87. Moriya T, Sasaki F, Mizui M, Ohno N, Mohri H, Mishiro S, et al. Transmission of hepatitis C virus from mothers to infants: its frequency and risk factors revisited Biomed Pbarmacother 1995;49:59-64.
88. Zuccoti GV, Ribero ML, Giovannini M, Fasola M, Riva E, Portera G, et al. Effect of hepatitis C genotype on mother-to-infant transmission of virus. J Pediatr 1995;127:278-80.
89. Resti M, Azzari C, Lega L, Rossi ME, Zammarchi E, Novembre E, et al. Mother-to-infant transmission of hepatitis C virus. Acta Paediatr 1995;84:251-5.
90. Ohio H, Terazawa S, Sasaki N, Sasaki N, Hino K, Ishiwata C, et al. Transmission of hepatitis C virus from mothers to infants. N Engl J Med 1994;330:744-50.
91. Grangé JD, Abergel A, Amiot X, Chaslin-Ferbus D, Aygalenq P, Fouqueray B, et al. Interactions entre l'hépatite virale chronique C et la grossesse. Gastroenterol Clin Biol 1995;19:520-4.
92. Inoue Y, Takeuchi K, Chou WH, Unayama T, Takanashi K, Saito I, et al. Silent mother-to-child transmission of hepatitis C virus through two generations determined by comparative nucleotide sequence analysis of the viral cDNA. J Infect Dis 1992;166:1425-8.
93. Mele A, Corona R, Tosti ME, Palumbo F, Moiraghi A, Novaco F, et al. Beauty treatments and risk of parenterally transmitted hepatitis: results from the hepatitis surveillance system in Italy. Scand J Infect Dis 1995;27:441-4.
94. Ko YC, Ho MS, Chiang TA, Chang SJ, Chang PY. Tattooing as a risk of hepatitis C virus infection. J Med Virol 1992;38:288-91.
95. Holsen DS, Harthug S, Myrmel H. Prevalence of antibodies to hepatitis C virus and association with intravenous drug abuse and tattooing in a national prison in Norway. Eur J Clin Microbiol Infect Dis 1993;12:673-6.
96. Rosman AS, Waraich A, Galvin K, Casiano J, Paronetto F, Lieber CS. Alcoholism is associated with hepatitis C but not hepatitis B in an urban population. Am J Gastroenterol 1995;3:498-505.
97. Shiell A, Briggs A, Farrell GC. The cost effectiveness of alpha interferon in the treatment of chronic active hepatitis C. Med J Aust 1994;160:268-72.
98. Pillonel J, Saura C, Couroucé AM. Dépistage des marqueurs d'une infection par le V.I.H., l'H.T.L.V. et les virus des hépatites B et C chez les donneurs de sang en France. Bull Epidemiol Hebdo 1996;3:9-11.
99. Roudot-Thoraval F, Deforges L, Girollet PP, Maria B, Milliez J, Pathier D, et al. Prévalence des anticorps dirigés contre le virus de l'hépatite C (tests ELISA 2 et RIBA 2) dans une population de femmes enceintes en France Gastroenterol Clin Biol 1992;16:255-9.
100. Dubois F, Desenclos JC, Mariotte N, Goudeau A, Séroprévalence de l'infection par le virus de l'hépatite C dans un échantillon national d'assurés sociaux volontaires àun examen de santé de la sécurité sociale. Bull Epidemiol Hebdo 1996;5:17-9.
101. Dubois F, François M, Mariotte N, Caces E, Vol S, Roingeard P, et al. Serum alanine aminotransferase measurement as a guide to selective testing for hepatitis C during medical checkup. J Hepatol 1994;21:837-41.
102. Lunel F, Rosenheim M, Duneton P. Propositions pour une stratégic d'évaluation et d'utilisation des tests de dépistage de l'hépatite C. Transfus Clin Biol 1996;5:279-88.